| Item 3.01. | Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing |
On April 29, 2008, Urologix, Inc. (the “Company”) received a Staff Deficiency Letter from The Nasdaq Stock Market which stated that the minimum bid price of the Company’s common stock was below $1.00 per share for 30 consecutive business days and that the Company was therefore not in compliance with Marketplace Rule 4450(a)(5). The Company has 180 days, or until October 27, 2008, to regain compliance. Compliance can be achieved during any compliance period by meeting the minimum bid price requirement for a minimum of 10 consecutive business days during the 180 day compliance period. This Staff Deficiency Letter has no effect on the listing of the Company common stock at this time.
| ITEM 9.01 | FINANCIAL STATEMENTS AND EXHIBITS |
| Exhibit No. |
Description | |
| 99.1 |
Press Release issued on May 2, 2008 by Urologix, Inc. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| UROLOGIX, INC. | ||
| By: | /s/ Mitchell Dann | |
| Mitchell Dann | ||
| Interim Chief Executive Officer | ||
Date: May 2, 2008